Source: Bloomberg Law

Davis Polk: Wachtell, Davis Polk Steer Mallinckrodt's $6.7 Billion Merger With Endo

Wachtell, Lipton, Rosen & Katz is steering Mallinckrodt Pharmaceuticals and Davis Polk & Wardwell is guiding Endo Inc. in their plans to merge, creating a $6.7 billion company.

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
Neil Barr's photo - Managing Partner of Davis Polk

Managing Partner

Neil Barr

CEO Approval Rating

56/100

Read more